Related Experiment Video
Updated: Jun 12, 2025

07:29
Zebrafish as a Model to Assess the Teratogenic Potential of Nitrite
Published on: February 16, 2016
9.4K
Birth defects and epidemiological factors in Tunisia
Kaouther Nasri1,2, Nadia Ben Jemaa3, Belhassen Chorfi2
1Faculty of Sciences of Bizerte, University of Carthage, 7021 Zarzouna, Bizerte Tunisia.
La Tunisie Medicale
|September 17, 2024
Summary
This study identified common birth defects in Tunisia, with neurological, nephro-urological, and cardiovascular anomalies being most frequent. It highlights the need for a national birth defect registry to improve statistics and care.
Area of Science:
- Medical Science
- Public Health
- Genetics
Background:
- Birth defects represent a significant global health concern.
- Accurate epidemiological data is crucial for understanding and addressing congenital anomalies.
Purpose of the Study:
- To identify and categorize birth defects in Tunisia.
- To investigate epidemiological factors associated with congenital anomalies.
Main Methods:
- A retrospective study of 2489 malformed cases (fetuses, stillborns, deceased newborns) was conducted.
- Data was collected from the embryo-fetopathology department of a maternity and neonatology center in Tunis.
Main Results:
- Neurological (26.01%), nephro-urological (13.16%), and cardiovascular (11.47%) anomalies were the most prevalent birth defects.
- Maternal age averaged 30.1 years, with high rates of parental consanguinity (37.4%) and reproductive failure history (32.5%).
- 164 polymalformative syndromes and 217 chromosomal aberrations were identified.
Conclusions:
- The study provides valuable insights into birth defect patterns and epidemiological factors in Tunisia.
- The absence of a national birth defect registry hinders comprehensive statistics.
- A national multicenter study is recommended to establish an accurate national register.
Related Concept Videos
Teratogenicity
2.4K
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
2.4K
Cancer Prevention
6.1K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
6.1K
Meiosis vs. Mitosis
54.1K
Cell division is necessary for growth and reproduction in organisms. Mitosis aids cell growth and development by dividing somatic cells. In contrast, meiosis causes the division of germ cells and plays an essential role in sexual reproduction. Due to their unique functional requirements, mitosis and meiosis differ from each other in multiple aspects.
Before the start of mitosis and meiosis I, the cell synthesizes DNA, resulting in two homologous copies of each chromosome. DNA synthesis is...
Before the start of mitosis and meiosis I, the cell synthesizes DNA, resulting in two homologous copies of each chromosome. DNA synthesis is...
54.1K
Nondisjunction
3.8K
Nondisjunction is the failure of homologous chromosomes or sister chromatids to separate correctly and move to the opposite poles of the cells. This produces daughter cells with abnormal chromosome numbers. Nondisjunction is common during anaphase I or anaphase II of meiosis. Mutations in synaptonemal complex proteins that attach homologous chromosomes increase the chances of nondisjunction in anaphase I of meiosis I. In contrast, mutations in topoisomerases and condensins that hold...
3.8K
Mutagenicity and Carcinogenicity
1.2K
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
1.2K
Probability Laws
40.7K
Overview
40.7K

